Orthocell Ltd has made its first commercial sales of Remplir, a nerve repair product, in Thailand following Thai FDA approval and the appointment of MediTime as its exclusive distributor. This launch opens access to Thailand's estimated $84 million nerve repair market and expands Orthocell's presence in Asia alongside existing markets like Australia, the US, and Singapore. Orthocell is supporting the launch with training and surgeon engagement, expecting modest initial sales but significant growth potential. The company also aims to enter the $750 million EU and UK nerve repair market pending regulatory approval later in 2026.
Orthocell's nerve repair product launch in Thailand comes as Pluang tracks 92 health-sector US stocks, with 52 rising and 40 falling today. Notable movers include DNA at USD 7.89 (+11.76%), CRSP at USD 57.10 (+9.37%), and ABCL at USD 12.70 (+8.83%). This data is current as of Sep 21, 2026 07:21 WIB.
Avalanche's AVAX price rose 18% due to three key events: New York Life Investment Management launched its first tokenized high-yield bond fund on Avalanche, Paxos added AVAX to its regulated payment services, and a network upgrade on September 22 wil...
Strategy (MSTR) stock surged 16.39%, closing at $153.92 after heavy trading volume more than doubling its average daily shares. The rise is closely tied to Bitcoin's price, as Strategy holds around 845,000 BTC worth about $69 billion, making Bitcoin'...
The USD1 stablecoin has surpassed $60 billion in cumulative trading volume on Binance since its launch in March 2025, with monthly volumes stabilizing between $5 billion and $8 billion. Backed by U.S. dollars and short-term Treasury bills, USD1 opera...
Bitcoin's price surged above $81,000 following the Federal Reserve's 25 basis point rate increase, despite the Senate's failure to advance the Digital Asset Market CLARITY Act. Arthur Hayes, BitMEX co-founder, argues that the rate hike, which increas...
Citi CEO Jane Fraser revealed that businesses worldwide are urgently enhancing their cybersecurity to counter AI-related threats, describing a "tsunami of patching" across firms. This surge in defenses follows warnings from AI developers like Anthrop...
